share_log

ReShape and Obalon Expect to Complete Merger After Market Close

Dow Jones Newswires ·  Jun 16, 2021 02:30

DJ ReShape and Obalon Expect to Complete Merger After Market Close

By Josh Beckerman

ReShape Lifesciences Inc. and Obalon Therapeutics Inc., which focus on medical devices for weight loss, expect to complete their merger after the close of the market Tuesday.

Shares of Nasdaq-listed Obalon were recently up 7% to $3.47. OTCQB-listed ReShape was down 7% to $5.11.

The merged company's stock is expected to begin trading on the Nasdaq Capital Market Wednesday, under the ReShape name and symbol "RSLS."

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

June 15, 2021 14:30 ET (18:30 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment